| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |